Yang Du

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Renal Cell Carcinoma

Long Noncoding Rna

Top Venues

Oxidative medicine and cellular longevity

Technology in cancer research & treatment

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng Lin Ye, Yang Du, Xi Yu, Zhi Yuan Chen, Lei Wang, Yong Fa Zheng, Xiu Heng Liu
STEAP3 Affects Ferroptosis and Progression of Renal Cell Carcinoma Through the p53/xCT Pathway. Technology in cancer research & treatment 21 (2022)
Yan Ze Li, Heng Cheng Zhu, Yang Du, Hong Chao Zhao, Lei Wang
Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling. Technology in cancer research & treatment 21 (2022)
Ye Zhang, Yanze Li, Qiangmin Qiu, Zhiyuan Chen, Yang Du, Xiuheng Liu
MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway. Oxidative medicine and cellular longevity 2022 (2022)
Yanze Li, Ye Zhang, Qiangmin Qiu, Lei Wang, Hu Mao, Juncheng Hu, Zhiyuan Chen, Yang Du, Xiuheng Liu
Energy-Stress-Mediated AMPK Activation Promotes GPX4-Dependent Ferroptosis through the JAK2/STAT3/P53 Axis in Renal Cancer. Oxidative medicine and cellular longevity 2022 (2022)
Bang-Hua Zhang, Hao Liu, Yan Yuan, Xiao-Dong Weng, Yang Du, Hui Chen, Zhi-Yuan Chen, Lei Wang, Xiu-Heng Liu
Knockdown of TRIM8 Protects HK-2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Inhibiting Oxidative Stress-Mediated Apoptosis and Pyroptosis via PI3K/Akt Signal Pathway. Drug design, development and therapy 15 (2021)